---
title: Avigen Ltd vs Distolife
slug_a: avigen
slug_b: distolife-shanghai-co-ltd
site: cro
review_signal_gate: closed
canonical_path: /compare/avigen/distolife-shanghai-co-ltd
generated_by: BioBM Editorial AI
---

# Avigen Ltd vs Distolife

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Avigen Ltd (avigen) is listed for cro. Avigen offers avidity-based profiling of live immune–target cell interactions for immunotherapy discovery and preclinical validation. Its platform supports TCR-T, CAR-T, and NK programmes across solid tumour indications.

Services: 2. Modalities: 1. Indications: 1. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (2).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

Distolife (distolife-shanghai-co-ltd) is listed for cro. Distolife is a CRO providing R&D support for complex membrane protein drug targets such as GPCRs, ion channels, and transporters. It also supplies biological reagents for structural biology and drug discovery.

Services: 1. Modalities: 0. Indications: 0. Locations: 0. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (1).

Review summary: Review summary withheld until site-level review gate opens.